J&J has received the US FDA approval for Rybrevant Faspro, a SC administered therapy to treat patients with EGFR-mutated ...

This year, there was a surge of new lung cancer treatments, more options for patients with earlier-stage disease, and growing ...

In a study published in The Journal of Clinical Investigation, University of Michigan researchers found a new protein target ...

Lung development begins during embryogenesis and continues after birth. It includes branching of airways, formation of ...

Long after their active duty ends, many veterans in North San Diego County, California, continue to shoulder the health risks ...

Mepolizumab reduced COPD exacerbations in patients with eosinophilic inflammation, highlighting the potential of ...

AI tools designed to diagnose cancer from tissue samples are quietly learning more than just disease patterns. New research ...

What will be the next blockbuster research to emerge from Princeton’s labs? No one can say for sure, but history tells us ...

Genmab (Otc) ($GMAB) announced an update on their ongoing clinical study. Genmab has announced a new Phase 2 clinical study designed to evaluate ...

A multidisciplinary team integrated clinical need, cancer biology, and microfluidic bioengineering to advance ...

Cancer researchers at the University of Tennessee Health Science Center have published three new studies demonstrating how ...

Cancer-diagnosing AI models can secretly read patient demographics from pathology slides, leading to biased results.